Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontier
Go back to Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontier| (NASDAQ: ANIX) | Delayed: 2.77 +0.01 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.76 | 52 Week High | $ | |||
| Open | $2.78 | 52 Week Low | $ | |||
| Day High | $2.79 | P/E | N/A | |||
| Day Low | $2.69 | EPS | $ | |||
| Volume | 315,203 | |||||
